Beneficial neurohormonal profile of spironolactone in severe congestive heart failure

This publication has 27 references indexed in Scilit:

• Effect of Carvedilol on Survival in Severe Chronic Heart Failure
  New England Journal of Medicine, 2001
• Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
  Circulation, 2000
• Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure
  Journal of Cardiac Failure, 2000
• Aldosterone and vascular damage
  Current Hypertension Reports, 2000
• Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure
  Circulation, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction
  Circulation, 1996
• Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril
  Journal of the American College of Cardiology, 1994
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
  Circulation, 1990